Medical Dictionary Search Engines

Please be patient! It may take up to ONE minute to load all the Engines.
Problems? Please contact our support.


Search For


Specialty Search




Other encyclopedia topics: A-Ag Ah-Ap Aq-Az B-Bk Bl-Bz C-Cg Ch-Co Cp-Cz D-Di Dj-Dz E-Ep Eq-Ez F G H-Hf Hg-Hz I-In Io-Iz J K L-Ln Lo-Lz M-Mf Mg-Mz N O P-Pl Pm-Pz Q R S-Sh Si-Sp Sq-Sz T-Tn To-Tz U V W X Y Z 0-9   

Chronic lymphocytic leukemia (CLL)

Alternative names



Chronic lymphocytic leukemia is a malignancy (cancer) of the white blood cells (lymphocytes) characterized by a slow, progressive increase of these cells in the blood and the bone marrow.

Causes, incidence, and risk factors

Chronic lymphocytic leukemia (CLL) affects the B lymphocytes and causes immunosuppression , failure of the bone marrow and invasion of malignant (cancerous) cells into organs.

Usually the symptoms develop gradually. The incidence is about 2 per 100,000 and increases with age. 90% of cases are found in people over 50 years old. Many cases are detected by routine blood tests in people with no symptoms. The cause of CLL is unknown. No relationship to radiation, carcinogenic chemicals or viruses has been determined. The disease is more common in Jewish people of Russian or Eastern European descent and is uncommon in Asia.


  • enlarged lymph nodes , liver or spleen
  • fatigue
  • abnormal bruising (occurs late in the disease)
  • sweating , excessive -- night sweats
  • loss of appetite
  • weight loss

Signs and tests

  • elevated white blood cell count in a CBC
  • flow cytometry revealing an abnormal population of white blood cells.
  • bone marrow aspiration
This disease may also alter the results of serum protein electrophoresis.


Early stage disease often requires no specific treatment (since early treatment does not improve survival), but close observation is important. Chemotherapy may be needed if a patient develops fatigue , anemia , thrombocytopenia or enlarged lymph nodes that are troublesome.

The anti-cancer medicine (chemotherapy) used first is usually fludarabine. Other medicines that may be used in this disease include chlorambucil (Leukeran) and cyclophosphamide (Cytoxan).

Recently, the drug alemtuzumab (Campath), which is an antibody against the surface of CLL cells, has been approved for treatment of patients with CLL who have failed fludarabine. Another antibody drug, rituximab (Rituxan), may also be used. Rarely, radiation may be used for enlarged lymph nodes. Blood transfusions or platelet transfusions may be required.

Support Groups

The stress of illness can often be helped by joining a support group where members share common experiences and problems.

Expectations (prognosis)

The prognosis depends on the stage of the disease. Half of patients diagnosed in the earliest stages of the disease live more than 12 years. On the other hand, if CLL has reached an advanced stage, about half of patients die within 2 years.


  • Increased risk of second malignancies
  • Side effects of chemotherapy
  • Bleeding from low platelets
  • Fatigue from anemia
  • Autoimmune hemolytic anemia
  • Idiopathic thrombocytopenic purpura (ITP)
  • Hypogammaglobulinemia (reduced levels of antibodies ) with increased susceptibility to infection

Calling your health care provider

Call health care provider if you develop enlarged lymph nodes or unexplained fatigue, bruising, excessive sweating, or weight loss.

Update Date: 8/4/2002

Scott Howard, M.D., M.S., Memphis, TN. Review provided by VeriMed Healthcare Network.

©2009 [Privacy Policy] [Disclaimer]
Last updated: Tue, 06 Jan 2009 00:20:03 GMT